Loading...
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies
BACKGROUND/AIMS: To evaluate intravitreal aflibercept versus laser in subgroups of patients with baseline Diabetic Retinopathy Severity Scale (DRSS) scores ≤43, 47, and ≥53 in VIVID-DME and VISTA-DME. METHODS: Patients with diabetic macular oedema were randomised to receive intravitreal aflibercept...
Na minha lista:
| Udgivet i: | Br J Ophthalmol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6047149/ https://ncbi.nlm.nih.gov/pubmed/29051325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-310664 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|